Skip to main content

Table 1 The percentage of CD133+ and CD15+ cells in NADHhigh/low subpopulations of glioma cell lines

From: Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma

Cell linesPercentage of CD133+ cellsPercentage of CD15+ cells
TotalNADHhighNADHlowTotalNADHhighNADHlow
GBM10.73 ± 0.042.10 ± 0.130.60 ± 0.130.50 ± 0.072.47 ± 0.440.43 ± 0.09
GBM20.47 ± 0.042.63 ± 0.240.43 ± 0.110.10.40 ± 0.130
T98G1.37 ± 0.222.27 ± 0.220.63 ± 0.314.77 ± 0.246.40 ± 0.076.23 ± 0.51
LN2290.53 ± 0.041.83 ± 0.180.80 ± 0.130.13 ± 0.040.67 ± 0.040.27 ± 0.04